CD274 and neoplasm: These results indicated that low-dose dexamethasone has anti-tumor activity by suppressing PD-L1 and IDO1, but high-dose dexamethasone induced tumor growth by suppressing tumor immune surveillance, which indicates dexamethasone as a double-edged sword [41].